Clinical Trial Update: Treatments for Anxiety: Meditation and Escitalopram [Phase 4]

View source ↗

Summary

Phase 4 trial update examining meditation and escitalopram for anxiety disorders, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agoraphobia
• Anxiety Disorders
• Generalized Anxiety Disorder
• Panic Disorder
• Social Anxiety Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Meditation (meditation)

Snippet

Sponsor: Georgetown University | Conditions: Anxiety Disorders, Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED